Serum Institute of India Ltd. Manufactures Anticancer Clispatin B.P Injection. Serum Institute of India Ltd. Supplies measles and DTP group of vaccines. Anticancer Clispatin B.P Injection is indicated as a single agent or in established combination therapy with other approved chemotherapeutic agents in metastatic testicular tumors; metastatic ovarian tumors; advanced bladder cancer. Anticancer Clispatin B.P Injection contains Cisplatin B.P., Mannitol B.P., Sodium Chloride B.P. And Water for Injection B.P. This injection can be available in the pack of 10 mg / 10 ml vial, 25 mg / 25 ml vial and 50 mg / 50 ml vial.
